These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 8000465)
1. Estrogen replacement therapy in women: prevention and treatment of coronary artery disease. Valle BK; Lemberg L Am J Crit Care; 1994 Sep; 3(5):398-401. PubMed ID: 8000465 [No Abstract] [Full Text] [Related]
2. [Menopause, hormonal replacement therapy, and coronary disease]. Gebara OC; Wajngarten M; Barretto AC; Bellotti G Arq Bras Cardiol; 1995 Apr; 64(4):355-8. PubMed ID: 7495396 [No Abstract] [Full Text] [Related]
3. [Estrogen replacement therapy and coronary disease]. Lengfelder W Dtsch Med Wochenschr; 2000 Sep; 125(37):1090-4. PubMed ID: 11036488 [No Abstract] [Full Text] [Related]
4. Where are we with postmenopausal hormone therapy in 2005? Lam PM; Chung TK; Haines C Gynecol Endocrinol; 2005 Nov; 21(5):248-56. PubMed ID: 16373243 [TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy, breast and endometrial cancer. La Vecchia C Eur J Cancer Prev; 1996 Oct; 5(5):414-6. PubMed ID: 8972283 [No Abstract] [Full Text] [Related]
6. Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force. U.S. Preventive Services Task Force Ann Intern Med; 2002 Nov; 137(10):I48. PubMed ID: 12435233 [No Abstract] [Full Text] [Related]
7. Use of HRT and the subsequent risk of cancer. Beral V; Banks E; Reeves G; Appleby P J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959 [TBL] [Abstract][Full Text] [Related]
8. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same. Do all the patients have the same characteristics?]. Mathelin C; Brettes JP Gynecol Obstet Fertil; 2007 Jun; 35(6):502-3. PubMed ID: 17543563 [No Abstract] [Full Text] [Related]
10. Page for patients. A message from Preventive Medicine and your physician. Prev Med; 1999 May; 28(5):465-6. PubMed ID: 10329336 [No Abstract] [Full Text] [Related]
11. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer]. Magnusson C; Weiderpass E Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082 [TBL] [Abstract][Full Text] [Related]
13. Estrogen and progestogen therapy in postmenopausal women. Practice Committee of the Americal Society for Reproductive Medicine Fertil Steril; 2004 Jan; 81(1):231-41. PubMed ID: 14711583 [No Abstract] [Full Text] [Related]
14. Breast cancer and hormonal therapy. Conner P; Lundström E; von Schoultz B Clin Obstet Gynecol; 2008 Sep; 51(3):592-606. PubMed ID: 18677153 [TBL] [Abstract][Full Text] [Related]
15. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis]. Brettes JP; Mathelin C Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474 [No Abstract] [Full Text] [Related]
18. The rationale for a wider range of progestogens. Skouby SO Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382 [TBL] [Abstract][Full Text] [Related]
19. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France]. Jamin C; Bourg F; Legeai J; Senoussi S Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401 [TBL] [Abstract][Full Text] [Related]
20. Estrogen therapy and cardiovascular risk in women. Bass KM; Bush TL J La State Med Soc; 1991 May; 143(5):33-9. PubMed ID: 1861096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]